Medicine Man Technologies, Inc.
SHWZ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.01 | -0.04 | 0.53 |
| FCF Yield | 4.03% | -4.50% | 67.20% | -17.21% |
| EV / EBITDA | 5.55 | 4.86 | 2.23 | -4.13 |
| Quality | ||||
| ROIC | 2.47% | 23.68% | 3.33% | -34.57% |
| Gross Margin | 44.09% | 53.35% | 45.52% | 28.23% |
| Cash Conversion Ratio | -0.35 | -0.62 | 3.95 | 0.50 |
| Growth | ||||
| Revenue 3-Year CAGR | 16.73% | 87.96% | 116.94% | 44.68% |
| Free Cash Flow Growth | 146.39% | -106.61% | 588.90% | -36.29% |
| Safety | ||||
| Net Debt / EBITDA | 4.52 | 2.87 | -0.00 | -1.03 |
| Interest Coverage | 0.10 | 0.43 | 1.48 | -552.41 |
| Efficiency | ||||
| Inventory Turnover | 3.74 | 3.30 | 5.31 | 6.58 |
| Cash Conversion Cycle | 56.13 | 68.35 | 65.77 | 3.43 |